“In addition, we review research evaluating potential pharmacotherapies (e.g., THC, a variety of antidepressant drugs , and lithium) to reduce cannabis withdrawal responses and examine how expanded knowledge about the regulatory mechanisms in the endocannabinoid system may lead to promising new therapeutic targets.”